Skip to main content
. 2021 May 12;2021:5548918. doi: 10.1155/2021/5548918

Figure 7.

Figure 7

The upregulation of CEP55 was correlated to the advanced stage of breast cancer. (a) CEP55 was remarkably upregulated in the advanced stage of breast cancer compared to the stage I breast cancer sample. (b) CEP55 was upregulated in luminal, HER2-positive, and triple-negative breast cancers compared to normal samples. (c) CEP55 was the most highly expressed in Basal-like 1 TNBC and Basal-like 2 TNBC samples but the most lowly expressed in mesenchymal stem-like TNBC samples.